跳至主要内容
临床试验/NCT06241066
NCT06241066已完成不适用

The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell Carcinoma

Tianjin Medical University Cancer Institute and Hospital1 个研究点 分布在 1 个国家目标入组 359 人开始时间: 2014年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
359
试验地点
1
主要终点
OS

研究概览

简要总结

Retrospective analysis of the presence and maturity of tertiary lymphoid structures in pathological sections of patients with esophageal squamous cell carcinoma after surgical treatment. Pay attention to the overall survival and disease free survival of these esophageal squamous cell carcinoma patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Pathologically diagnosed as esophageal squamous cell carcinoma;
  • Surgery for esophageal cancer;
  • Complete medical records;

排除标准

  • Patients with a previous history of malignant tumor

结局指标

主要结局

OS

时间窗: The time from treatment to death or last follow-up, assessed up to 100 months.

Overall Survival

DFS

时间窗: The time from treatment to the first recurrence or last follow-up, assessed up to 100 months.

Disease-free Survival

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验